Takeda Moves to Join Pharma Giants With $62 Billion Shire DealBy
Japanese drugmaker secures $31 billion bridge loan from banks
- CEO Weber says deal transforms company, giving it global reach
Chief Executive Officer Christophe Weber capped a drawn-out pursuit of the U.K.-listed company with an acquisition he described as transformational that will give Takeda wider reach into the world’s biggest drug market and strengthen its global pipeline for lucrative drugs that treat rare diseases…
Leave a Reply
You must be logged in to post a comment.